Women's Health
FDA Office of Women's Health (OWH)
OWH protects and promotes the health of women through policy, science, education, and outreach.
Featured
Women's Health Research Roadmap
The Roadmap provides a framework for integrating women’s health science into all of FDA’s research activities.
Sex as a Biological Variable
Understanding mechanisms of sex differences in medical product development is crucial for regulatory decisions and optimal treatment outcomes.
Pregnancy Exposure Registries
Pregnancy exposure registries are research studies that collect health information on exposure to medical products such as medicines (drugs) and vaccines during pregnancy.
Clinical Lactation Studies
Clinical lactation studies are research studies that collect health information about the effects of medical products used while breastfeeding may have on you and/or your breast-fed baby.
Draft Guidance on the Inclusion of Pregnant/Breastfeeding Women in Clinical Tri…
The draft guideline provides recommendations for the inclusion and/or retention of pregnant and breastfeeding women in clinical trials.
Menopause: Potential Impact on Clinical Pharmacology
This workshop examines the physiologic changes that occur during menopause and the potential effects of menopause on the pharmacokinetics and pharmacodynamics of drugs.
Paragraph Header
Contact Us
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993